Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $7.4 million.

  • Artiva Biotherapeutics' Non-cash Items fell 5724.27% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year decrease of 5724.27%. This contributed to the annual value of $10.4 million for FY2024, which is 475981.31% up from last year.
  • Latest data reveals that Artiva Biotherapeutics reported Non-cash Items of $7.4 million as of Q3 2025, which was down 5724.27% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Artiva Biotherapeutics' Non-cash Items ranged from a high of $17.3 million in Q3 2024 and a low of $214000.0 during Q4 2023
  • Moreover, its 3-year median value for Non-cash Items was $8.4 million (2025), whereas its average is $7.6 million.
  • Per our database at Business Quant, Artiva Biotherapeutics' Non-cash Items skyrocketed by 475981.31% in 2024 and then tumbled by 5724.27% in 2025.
  • Over the past 3 years, Artiva Biotherapeutics' Non-cash Items (Quarter) stood at $214000.0 in 2023, then soared by 4759.81% to $10.4 million in 2024, then fell by 28.85% to $7.4 million in 2025.
  • Its Non-cash Items was $7.4 million in Q3 2025, compared to $1.2 million in Q2 2025 and $9.4 million in Q1 2025.